Are GLP-1 agonists effective for weight loss in obese nondiabetic pediatric patients?doi:10.1097/EBP.0000000000001644Wala ToutPriya NagarajanWolters KluwerEvidence-Based Practice
GLP-1 drugs, also known as GLP-1 agonists, GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs, are commonly used to treat type 2 diabetes. [1, 2]In recent years, however, healthcare providers have also been prescribing GLP-1 medication to support weight loss. Such is the ...
The GLP-1 (glucagon-like peptide-1) receptor agonists approved for weight loss include Wegovy (semaglutide) and Saxenda (liraglutide). They are also given by subcutaneous injection and result in significant weight loss. Wegovy and Saxenda are both used in people 12 years and older but Wegovy ...
Here we combine cryo-electron microscopy, molecular dynamics simulations, receptor mutagenesis and pharmacological assays, to interrogate the mechanism and consequences of GLP-1R binding to four peptide agonists; glucagon-like peptide-1, oxyntomodulin, exendin-4 and exendin-P5. These data reveal that ...
GLP-1 (Glucagon-like peptide-1) apps are designed to support individuals who are prescribed GLP-1 receptor agonists, a class of medications commonly used to treat type 2 diabetes. These apps typically offer features that help users manage their diabetes, monitor their GLP-1 therapy, and make ...
Thrombopoietin receptor agonists are currently under clinical investigation for the treatment of ITP and may represent an alternative treatment option in the ... F Rodeghiero - 《Eur J Haematol Suppl》 被引量: 76发表: 2008年 GLP-1 receptor agonists have a sustained stimulatory effect on corticost...
Glucagon-like peptide-1 (GLP-1) receptor agonists, otherwise known as GLP-1 drugs, have attracted increasing attention over the past year as more research has proven their efficacy in managing weight in patients with overweight and obesity. While these drugs were initially designed forman...
Wegovy belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1RAs) that act by mimicking the hormone GLP-1, which is released after eating. The class of drugs also includes medications for type 2 diabetes, such as Ozempic and Rybelsus, that are increasingly used...
Incretin-based therapies, such as dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), have become widely available for the management of T2D. Incretins, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide-1 are secreted from the ...
also to make the medical plan.Complete surgical excision is needed. Medical resection may be the only effective means for the treating laryngocele.Objective To explore the imaging assessment of cerebrospinal substance (CSF) otorrhea associated with internal ear malformation (IEM) in children. Methods ...